|
Volumn 448, Issue 2-3, 2002, Pages 245-252
|
Reduction of blood glucose level by orexins in fasting normal and streptozotocin-diabetic mice
|
Author keywords
(Mouse); Diabetes; Fasting; Glycemia; Orexin
|
Indexed keywords
ANTIDIABETIC AGENT;
GLIBENCLAMIDE;
GLUCOSE;
INSULIN;
OREXIN A;
OREXIN B;
CARRIER PROTEIN;
NEUROPEPTIDE;
OREXINS;
SIGNAL PEPTIDE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
DIET RESTRICTION;
DRUG EFFECT;
DRUG MECHANISM;
FEEDING;
FOOD;
GLUCOSE BLOOD LEVEL;
GLUCOSE UTILIZATION;
HORMONAL REGULATION;
INSULIN BLOOD LEVEL;
MALE;
MOUSE;
NERVE CELL;
NONHUMAN;
PRIORITY JOURNAL;
STREPTOZOCIN DIABETES;
ANIMAL;
BLOOD;
COMPARATIVE STUDY;
DOSE RESPONSE;
DOWN REGULATION;
EXPERIMENTAL DIABETES MELLITUS;
INTRACEREBROVENTRICULAR DRUG ADMINISTRATION;
METABOLISM;
PHYSIOLOGY;
ANIMAL;
BLOOD GLUCOSE;
CARRIER PROTEINS;
COMPARATIVE STUDY;
DIABETES MELLITUS, EXPERIMENTAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOWN-REGULATION;
FASTING;
INJECTIONS, INTRAVENTRICULAR;
MALE;
MICE;
NEUROPEPTIDES;
SUPPORT, NON-U.S. GOV'T;
ANIMALS;
INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;
|
EID: 0037135039
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-2999(02)01936-2 Document Type: Article |
Times cited : (36)
|
References (33)
|